The commercial success of GLP-1 receptor agonists has done something unusual for a pharmaceutical category: it has generated an entirely new HealthTech sector almost overnight. …
The commercial success of GLP-1 receptor agonists has done something unusual for a pharmaceutical category: it has generated an entirely new HealthTech sector almost overnight. …
The Chief Product Officer role in HealthTech has always been more complex than its equivalent in consumer software. Clinical validation, regulatory pathway, patient safety obligations…